228 related articles for article (PubMed ID: 32327294)
1. The Role of Heat Shock Protein-90 in the Pathogenesis of Birt-Hogg-Dubé and Tuberous Sclerosis Complex Syndromes.
Woodford MR; Backe SJ; Sager RA; Bourboulia D; Bratslavsky G; Mollapour M
Urol Oncol; 2021 Jun; 39(6):322-326. PubMed ID: 32327294
[TBL] [Abstract][Full Text] [Related]
2. Sporadic renal angiomyolipoma in a patient with Birt-Hogg-Dubé: chaperones in pathogenesis.
Sager RA; Woodford MR; Shapiro O; Mollapour M; Bratslavsky G
Oncotarget; 2018 Apr; 9(31):22220-22229. PubMed ID: 29774133
[TBL] [Abstract][Full Text] [Related]
3. Renal angiomyolipoma in Birt-Hogg-Dube syndrome: A case study supporting overlap with tuberous sclerosis complex.
Dow E; Winship I
Am J Med Genet A; 2016 Dec; 170(12):3323-3326. PubMed ID: 27643397
[TBL] [Abstract][Full Text] [Related]
4. Birt-Hogg-Dubé syndrome with a renal angiomyolipoma: further evidence of a relationship between Birt-Hogg-Dubé syndrome and tuberous sclerosis complex.
Byrne M; Mallipeddi R; Pichert G; Whittaker S
Australas J Dermatol; 2012 May; 53(2):151-4. PubMed ID: 22571569
[TBL] [Abstract][Full Text] [Related]
5. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
[TBL] [Abstract][Full Text] [Related]
6. Renal Cell Carcinoma in Tuberous Sclerosis Complex.
Henske EP; Cornejo KM; Wu CL
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680979
[TBL] [Abstract][Full Text] [Related]
7. [Renal cancer and hereditary diseases].
Maurin C
Prog Urol; 2013 Nov; 23(14):1157-62. PubMed ID: 24176402
[TBL] [Abstract][Full Text] [Related]
8. Emerging Link between Tsc1 and FNIP Co-Chaperones of Hsp90 and Cancer.
Backe SJ; Sager RA; Meluni KA; Woodford MR; Bourboulia D; Mollapour M
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883484
[TBL] [Abstract][Full Text] [Related]
9. Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms.
Bonsib SM; Boils C; Gokden N; Grignon D; Gu X; Higgins JP; Leroy X; McKenney JK; Nasr SH; Phillips C; Sangoi AR; Wilson J; Zhang PL
Pathol Res Pract; 2016 Nov; 212(11):972-979. PubMed ID: 27640314
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dubé Syndrome].
Tohi Y; Makita N; Suzuki I; Suzuki R; Fukunaga A; Kubota M; Matsuoka T; Sugino Y; Inoue K; Uehara K; Imai Y; Kawakita M
Hinyokika Kiyo; 2018 Mar; 64(3):107-110. PubMed ID: 29684959
[TBL] [Abstract][Full Text] [Related]
11. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
[TBL] [Abstract][Full Text] [Related]
12. Absence of the Birt-Hogg-Dubé gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility.
Preston RS; Philp A; Claessens T; Gijezen L; Dydensborg AB; Dunlop EA; Harper KT; Brinkhuizen T; Menko FH; Davies DM; Land SC; Pause A; Baar K; van Steensel MA; Tee AR
Oncogene; 2011 Mar; 30(10):1159-73. PubMed ID: 21057536
[TBL] [Abstract][Full Text] [Related]
13. Syndrome of Birt-Hogg-Dubé, a histopathological pitfall with similarities to tuberous sclerosis: a report of three cases.
Spring P; Fellmann F; Giraud S; Clayton H; Hohl D
Am J Dermatopathol; 2013 Apr; 35(2):241-5. PubMed ID: 23542717
[TBL] [Abstract][Full Text] [Related]
14. Hereditary Renal Cancer Syndromes.
Yanus GA; Kuligina ES; Imyanitov EN
Med Sci (Basel); 2024 Feb; 12(1):. PubMed ID: 38390862
[TBL] [Abstract][Full Text] [Related]
15. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
[TBL] [Abstract][Full Text] [Related]
16. Birt-Hogg-Dubé syndrome: novel FLCN frameshift deletion in daughter and father with renal cell carcinomas.
Näf E; Laubscher D; Hopfer H; Streit M; Matyas G
Fam Cancer; 2016 Jan; 15(1):127-32. PubMed ID: 26342594
[TBL] [Abstract][Full Text] [Related]
17. Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study.
Benusiglio PR; Giraud S; Deveaux S; Méjean A; Correas JM; Joly D; Timsit MO; Ferlicot S; Verkarre V; Abadie C; Chauveau D; Leroux D; Avril MF; Cordier JF; Richard S;
Orphanet J Rare Dis; 2014 Oct; 9():163. PubMed ID: 25519458
[TBL] [Abstract][Full Text] [Related]
18. Kidney cancer: Links between hereditary syndromes and sporadic tumorigenesis.
Alchoueiry M; Cornejo K; Henske EP
Semin Diagn Pathol; 2024 Jan; 41(1):1-7. PubMed ID: 38008653
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetics and clinical features of Birt-Hogg-Dubé syndrome.
Schmidt LS; Linehan WM
Nat Rev Urol; 2015 Oct; 12(10):558-69. PubMed ID: 26334087
[TBL] [Abstract][Full Text] [Related]
20. The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis.
Hartman TR; Nicolas E; Klein-Szanto A; Al-Saleem T; Cash TP; Simon MC; Henske EP
Oncogene; 2009 Apr; 28(13):1594-604. PubMed ID: 19234517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
